NURSICA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NURSICA
Largest movements
- Receivables after one year -€2,410
down €2,410 (-3.1%), from €78,957 to €76,547
- Accrued charges and deferred income -€4,726
down €4,726 (-8.4%), from €56,212 to €51,486
- Reserves +€1,635
up €1,635 (+22.7%), from €7,197 to €8,832
of which Distributable reserves: +€1,635
- Gross operating margin +€3,527
up €3,527, from -€1,816 to €1,711
- Financial income -€51
down €51 (-59.4%), from €85 to €35
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €79,254 | €76,879 | -€2,374 | -3.0% |
| Current assets | 29/58 | €79,254 | €76,879 | -€2,374 | -3.0% |
| Amounts receivable after more than one year | 29 | €78,957 | €76,547 | -€2,410 | -3.1% |
| Other amounts receivable | 291 | €78,957 | €76,547 | -€2,410 | -3.1% |
| Cash at bank and in hand | 54/58 | €4 | €5 | +€1 | +28.9% |
| Deferred charges and accrued income | 490/1 | €292 | €327 | +€35 | +11.8% |
| Total equity and liabilities | 10/49 | €79,254 | €76,879 | -€2,374 | -3.0% |
| Equity | 10/15 | €22,407 | €24,042 | +€1,635 | +7.3% |
| Contributions | 10/11 | €15,210 | €15,210 | = | 0.0% |
| Reserves | 13 | €7,197 | €8,832 | +€1,635 | +22.7% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €5,337 | €6,972 | +€1,635 | +30.6% |
| Amounts payable | 17/49 | €56,847 | €52,838 | -€4,009 | -7.1% |
| Amounts payable within one year | 42/48 | €635 | €1,351 | +€717 | +113% |
| Trade debts | 44 | €515 | €1,231 | +€717 | +139% |
| Suppliers | 440/4 | €515 | €1,231 | +€717 | +139% |
| Other amounts payable | 47/48 | €120 | €120 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €56,212 | €51,486 | -€4,726 | -8.4% |
| Other operating charges | 640/8 | €64 | €66 | +€2 | +3.0% |
| Gross operating margin | 9900 | -€1,816 | €1,711 | +€3,527 | |
| Operating profit (loss) | 9901 | -€1,880 | €1,645 | +€3,525 | |
| Financial income | 75/76B | €85 | €35 | -€51 | -59.4% |
| Recurring financial income | 75 | €85 | €35 | -€51 | -59.4% |
| Financial charges | 65/66B | €51 | €45 | -€6 | -11.6% |
| Recurring financial charges | 65 | €51 | €45 | -€6 | -11.6% |
| Profit (loss) for the period before taxes | 9903 | -€1,846 | €1,635 | +€3,480 | |
| Profit (loss) for the period | 9904 | -€1,846 | €1,635 | +€3,480 | |
| Profit (loss) for the period to be appropriated | 9905 | -€1,846 | €1,635 | +€3,480 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.